CLX vs DEO Stock Comparison

Compare CLX and DEO across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.

Market data as of Sep 11, 2026 market close· AIQ score gap 8 points
CLX
Consumer Defensive
vs
DEO
Consumer Defensive
CLX
The Clorox Company
Price
$87.76
Day move
-1.14%
AIQ Score
30/100
Best edge
Value
Sector
Consumer Defensive
DEO
Diageo plc
Leads
Price
$86.63
Day move
+0.37%
AIQ Score
38/100
Best edge
Quality
Sector
Consumer Defensive

What is the main difference between CLX and DEO?

DEO leads the current stock comparison as Diageo plc, with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

The Clorox Company vs Diageo plc

Data as of Sep 11, 2026· market close· Consumer Defensive· Coverage 66/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 6/10

DEO leads

DEO leads by 8 AIQ points, primarily on Quality and Risk Resilience, and the lead has widened from 5 points over 30 sessions.

Competitive: 4 of 6 evidence groups support DEO, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Strengthening
CLX

The Clorox Company

AIQ Score
30/100
AIQ Edge Score
1/10
DEO

Diageo plc

Leads
AIQ Score
38/100
AIQ Edge Score
2/10

The Algovestiq AIQ Score currently favors DEO over CLX, 38 versus 30 as of Sep 11, 2026. DEO's advantage is driven primarily by stronger quality and risk resilience, while CLX holds the stronger value profile. DEO also shows the stronger technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor DEO today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. DEO lead: Strengthening — the AIQ differential moved from 5 to 8 points over 30 sessions.

Compare The Clorox Company and Diageo plc across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price-return comparison using available daily close history.

CLX
-48.2%
DEO
-55.7%

Total return comparison

Growth of $10,000

CLX $5,185 · DEO $4,428

Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.

Compare CLX and DEO against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

CLX advantage
0
DEO advantage
  • Quality19 vs 42
    DEO +23
  • Risk Resilience40 vs 51
    DEO +11
  • Value46 vs 37
    CLX +9
  • Momentum19 vs 28
    DEO +9

4 of 6 evidence groups favor DEO. DEO’s edge is concentrated in quality and risk resilience; CLX keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.

CLX0 AIQ

No factor moved materially.

No new signals fired.

DEO0 AIQ

No factor moved materially.

New signals

  • RSI Oversold - Potential Bounce bullish, momentum, short horizon

DEO's lead was unchanged in the latest snapshot.

Deeper signal detail for each name lives on its own signals page — CLX and DEO both carry a full feed there.

The central trade-off

DEO (Diageo plc): the stronger current systematic profile, led by quality and risk resilience.

CLX (The Clorox Company): the counter-case, on value, valuation.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

DEO

DEO on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

CLX

CLX on combined revenue and EPS growth.

Value

CLX

CLX on the peer-relative Value factor, by 9 points.

Momentum

DEO

DEO on the Momentum factor, by 9 points.

Lower downside

DEO

DEO on Risk Resilience, by 11 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureCLXDEONote
Implied upside to target+14.9%+14.3%Level
Target dispersion+55.5%0%Lower is tighter analyst agreement
ConsensusHoldHoldContext, not a primary driver
Analysts covering91Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor DEO. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreDEO30 vs 38
FundamentalsDEOon balancerevenue growth 16.6% vs -11.8%; EPS growth -13% vs -112.4%; TTM ROE -18.9% vs 15.5%; gross margin 42.3% vs 59.5%; operating margin 24.7% vs 28.4% — DEO takes 3 of 5 decided legs, not all of them
ValuationCLXValue 46 vs 37
TechnicalsDEOPrice vs 50-day -11.8% vs -2%; vs 200-day -13.8% vs 0.7%
Risk ResilienceDEORisk Resilience 40 vs 51
Analyst expectationsEvenTarget upside 14.9% vs 14.3%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CLX and DEO and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is moderate at 8 points.
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on DEO.

How the comparison changed

119 daily snapshots · May 4 Sep 10

DEO lead: Strengthening — the AIQ differential moved from 5 to 8 points over 30 sessions.

May 4CLX leads above the line · DEO leads belowSep 10
Today
DEO +8
30 vs 38
7 sessions ago
DEO +14
30 vs 44
30 sessions ago
DEO +5
43 vs 48
90 sessions ago
DEO +8
38 vs 46

The lead changed hands 2 times in this window, most recently on Jun 11 when DEO moved ahead of CLX.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

CLXConflicted

1 bullish / 4 bearish, conflicted

  • Death Cross Active bearish, trend, long horizon (3.59%)
  • Keltner Channel Breakdown bearish, volatility, short horizon
  • RSI Oversold - Potential Bounce bullish, momentum, short horizon
DEOConflicted

2 bullish / 2 bearish, conflicted

  • Golden Cross Active bullish, trend, long horizon (3.11%)
  • Keltner Channel Breakdown bearish, volatility, short horizon
  • RSI Oversold - Potential Bounce bullish, momentum, short horizon

DEO leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

CLXNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.14%, AIQ 0 points).

DEONo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.37%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1CLX closes the Quality gap — currently 23 points behind, the largest single contributor to DEO's edge.
  2. 2CLX's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3DEO's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
  4. 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

DEO leads on balance
MetricCLXDEO
Revenue growth (YoY)16.6%-11.8%
EPS growth (YoY)-13%-112.4%
Gross margin42.3%59.5%
Operating margin24.7%28.4%
Return on equity (TTM)-18.9%15.5%
Debt to equity61.332.03

Performance

DEO leads 6 of 6 windows
MetricCLXDEO
1 week (5 sessions)-5.8%-5.3%
1 month (20 sessions)-16.1%-8.1%
3 months (63 sessions)-10.6%8.2%
6 months (126 sessions)-20.8%8.3%
Year to date-12%0%
1 year (252 sessions)-29.5%-18.9%

Technicals

DEO has the stronger structure
MetricCLXDEO
RSI (14)16.827
ADX (14)30.118
Price vs 50-day-11.8%-2%
Price vs 200-day-13.8%0.7%
Volatility (1M, annualized)23.5%24.5%

Risk

DEO is the more resilient
MetricCLXDEO
Beta0.240.26
Sharpe ratio-1.1-0.54
Sortino ratio-1.51-0.71
Max drawdown-32.3%-31%
Current drawdown-30.2%-17.8%
Annualized volatility30.9%33.1%
Value at risk (95%)-3.1%-2.7%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, CLX or DEO?

On the Algovestiq AIQ Score, DEO is the stronger of the two as of Sep 11, 2026, scoring 38 against CLX's 30. The edge comes from quality and risk resilience. CLX is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is CLX or DEO the better buy right now?

DEO carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor DEO over CLX?

The composite weights Quality, Value, Momentum and Risk Resilience. DEO leads Quality by 23 points; DEO leads Risk Resilience by 11 points; CLX leads Value by 9 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, CLX or DEO?

Analyst price targets imply +14.9% upside for CLX and +14.3% for DEO. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, CLX or DEO?

CLX is the better-valued of the two on the peer-relative Value factor. CLX on the peer-relative Value factor, by 9 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, CLX or DEO?

CLX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, CLX or DEO?

DEO on the Momentum factor, by 9 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, CLX or DEO?

DEO is the more resilient of the two, so the other name carries the higher downside risk. DEO on Risk Resilience, by 11 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is CLX more profitable than DEO?

DEO leads on the comparable margin measures — gross margin 42.3% vs 59.5%; operating margin 24.7% vs 28.4%; ttm roe -18.9% vs 15.5%.

Is DEO's lead over CLX getting stronger or weaker?

DEO lead: Strengthening — the AIQ differential moved from 5 to 8 points over 30 sessions. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 2 times in that window, most recently on 2026-06-11, when DEO moved ahead of CLX.

What would change the CLX vs DEO verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CLX closes the Quality gap — currently 23 points behind, the largest single contributor to DEO's edge; CLX's Death Cross Active resolves — a bearish trend rule currently active against it; DEO's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

What do the current signals say about CLX and DEO?

CLX: 1 bullish / 4 bearish, conflicted. DEO: 2 bullish / 2 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CLX is Death Cross Active (bearish, long horizon). On DEO it is Golden Cross Active (bullish, long horizon).

Compare CLX and DEO with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.